Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined Tribenoside/Lidocaine Rectal Cream (Procto-Glyvenol<sup>®</sup>) Promotes Tissue Repair in a Preclinical Model of Acute Complicated Anal Fissure.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Dinutuximab beta effectively treats Ewing sarcoma when combined with chemotherapy.

iScience·2026
Same author

Spatially Precise and Minimally Invasive Delivery of Peptides to the Spinal Cord for Behavior Modulation.

ACS nano·2024
Same author

Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation.

Nature cardiovascular research·2024
Same author

Case report: STRN3-NTRK3 fusion in uterine sarcoma with spleen metastasis: a new variant in the spectrum of NTRK-rearranged tumors.

Frontiers in medicine·2024
Same author

Epigenetic regulation by polycomb repressive complex 1 promotes cerebral cavernous malformations.

EMBO molecular medicine·2024

Related Experiment Video

Updated: Mar 7, 2026

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

11.4K

Endothelial cell disease: emerging knowledge from cerebral cavernous malformations.

Maria Grazia Lampugnani1, Matteo Malinverno, Elisabetta Dejana

  • 1aFondazione Italiana per la Ricerca sul Cancro (FIRC) Institute of Molecular Oncology Fondazione bMario Negri Institute for Pharmacological Research, Milan, Italy cDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden dDepartment of Biosciences, School of Sciences and Department of Oncology, School of Medicine, Milano University, Milan, Italy.

Current Opinion in Hematology
|February 18, 2017
PubMed
Summary

Cerebral cavernous malformations (CCMs) result from genetic mutations causing endothelial cell dysfunction. Understanding these defects may lead to new treatments for this incurable vascular disease.

More Related Videos

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice
04:29

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice

Published on: May 17, 2024

1.2K
Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model
09:36

Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model

Published on: August 29, 2012

19.6K

Related Experiment Videos

Last Updated: Mar 7, 2026

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

11.4K
Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice
04:29

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice

Published on: May 17, 2024

1.2K
Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model
09:36

Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model

Published on: August 29, 2012

19.6K

Area of Science:

  • Vascular Biology
  • Genetics
  • Cell Biology

Background:

  • Endothelial cell dysfunction is implicated in various human diseases.
  • Cerebral cavernous malformations (CCMs) are vascular defects in the central nervous system caused by mutations in CCM genes.
  • These mutations lead to fragile, permeable microvessels, causing neurological symptoms and stroke.

Purpose of the Study:

  • To review recent findings on endothelial cell defects in CCMs, focusing on adherens junctions.
  • To explore molecular alterations resulting from CCM gene mutations.
  • To identify potential targets for pharmacological interventions.

Main Methods:

  • Review of recent scientific literature on CCMs and endothelial cell biology.
  • Analysis of molecular signaling pathways affected by CCM gene mutations.
  • Comparison of genotype-specific defects in CCM1, CCM2, and CCM3.

Main Results:

  • CCMs are currently incurable, with no pharmacological treatments available beyond surgery.
  • Loss-of-function mutations in CCM genes trigger similar signaling pathway alterations and mesenchymal marker acquisition in endothelial cells.
  • Genotype-specific endothelial defects are observed, particularly in CCM1 and CCM3 mutations.

Conclusions:

  • Characterizing endothelial alterations in CCMs offers insights into fundamental molecular regulations of endothelial cell behavior.
  • This research may illuminate the mechanisms of endothelial cell specificity in different organs and vascular sites.
  • Understanding CCM pathogenesis could pave the way for targeted therapeutic strategies.